StockData
Acurx Pharmaceuticals, Inc. logo

Acurx Pharmaceuticals, Inc. (ACXP) stock

ACXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.00+0.01 (+1.01%)

Close on Nov 18, 2026Market cap $5.27MP/E –Yield –

Acurx Pharmaceuticals free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Acurx Pharmaceuticals

Acurx Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Acurx Pharmaceuticals figures

See a number that looks wrong?